Eli Lilly and Company LLY
Regular-session close
After hours · Nov 16, 7:59 PM ET
- YTD
- +33.22%
- 1 year
- +39.64%
Discussion (582)
$LLY Never thought it’s not a good company, but not a good time to buy right now. You better wait until the stock stops dropping and chopping. The price probably will be around $600-$800 , depending market situation. CTA might begin to sell and you will see the price drop pretty soon .
$LLY?Total Gift at these prices. Going Higher
$LLY When it rise above $1000 then we talk about recovery. Now it’s really a big chance that it will keep dropping below $900. If you would like to add your lots better wait until it stops to drop and the price is choppy. I guess maybe $600-800. Don’t join in the club too early.
$LLY..ADDED 10 stocks..Selling nonsense here..analysts target 1.300-1.500$
$LLY..ADDED..I never sell this stock..longhold pos since 11 years
Greetings from Germany
$LLY Remember the guys who said $1000 was a good buying. Big chance it will drop below $900 , let’s see if it will stop at that position or not.
$LLY If this stock keeps grinding like this, it will eventually break below the $1000 level.
Early research suggests Retatrutide (a "triple-G" agonist) may lead to significantly greater weight loss than Zepbound (a "dual-G" agonist), potentially setting a new standard for obesity treatment.
$LLY
Retatrutide—A Game Changer in Obesity Pharmacotherapy - When this Lily GLP drug gets FDA approved- It will destroy the other GLP’s. The peptides for it are going through the roof and no one is even talking about the others. It’s all about RETA
$LLY
